4//SEC Filing
Reich Samuel J 4
Accession 0001209191-22-031398
CIK 0001833214other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:45 PM ET
Size
7.3 KB
Accession
0001209191-22-031398
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO & EXECUTIVE CHAIRMAN
Transactions
- Other
Common Stock
2022-05-20−2,500,127→ 547,698 total(indirect: By LLC) - Other
Common Stock
2022-05-20+207,001→ 208,001 total
Footnotes (2)
- [F1]Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
- [F2]The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001394645
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:45 PM ET
- Size
- 7.3 KB